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Abstract
Background: Conditional reprogramming has enabled the development of long-lived, normal epithelial cell lines
from mice and humans by in vitro culture with ROCK inhibitor on a feeder layer. We applied this technology to
mouse small intestine to create 2D mouse intestinal epithelial monolayers (IEC monolayers) from genetic mouse
models for functional analysis.
Results: IEC monolayers form epithelial colonies that proliferate on a feeder cell layer and are able to maintain their
genotype over long-term passage. IEC monolayers form 3D spheroids in matrigel culture and monolayers on
transwell inserts making them useful for functional analyses. IEC monolayers derived from the Cystic Fibrosis (CF)
mouse model CFTR ΔF508 fail to respond to CFTR activator forskolin in 3D matrigel culture as measured by
spheroid swelling and transwell monolayer culture via Ussing chamber electrophysiology. Tumor IEC monolayers
generated from the ApcMin/+ mouse intestinal cancer model grow more quickly than wild-type (WT) IEC monolayers
both on feeders and as spheroids in matrigel culture.
Conclusions: These results indicate that generation of IEC monolayers is a useful model system for growing large
numbers of genotype-specific mouse intestinal epithelial cells that may be used in functional studies to examine
molecular mechanisms of disease and to identify and assess novel therapeutic compounds.
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Background
The goal of intestinal epithelial cell culture is to model
intestinal physiology and disease in vitro. Traditional
methods that have been used to study intestinal epithe-
lial cell function and intestinal physiology in vitro in-
clude immortalized cell lines, 3-dimensional (3D)
organoid culture and directed differentiation of pluripo-
tent stem cells (PSC). Immortalized intestinal epithelial
cell lines are derived from cancerous tissue or from nor-
mal tissue that has been transformed with an oncogene
to allow extensive expansion as a monolayer. These lines
of cells propagate quickly and some are able to form dif-
ferentiated, functional intestinal epithelial cell types. For
example, the human colorectal adenocarcinoma cell line
Caco-2 can spontaneously differentiate into enterocytes
and has been successfully used in barrier function assays
[1]. However, immortalized intestinal epithelial cell lines
demonstrate many limitations including genetic instabil-
ity and aneuploidy in some lines. Their extensive differ-
entiation time or complete lack of differentiation has
resulted in limited usefulness to model intestinal physi-
ology. The development of 3D matrigel culture systems
has allowed for the expansion and differentiation of nor-
mal intestinal epithelial cells in vitro and is a powerful
tool to study intestinal epithelial stem cell (IESC) differ-
entiation and function [2]. Since expansion of organoids
from single Lgr5-positive intestinal stem cells (ISCs) was
described in Sato et al. [2], 3D organoid culture has been
applied in modelling human colorectal cancer [3–5],
personalized cancer therapy and drug screening [6, 7]
and regenerative medicine [8, 9]. Recent publications
have demonstrated the ability of organoids to create a
polarized epithelial monolayer that is capable of
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transport in a transwell culture system, which makes it a
useful model for mechanistic studies of barrier function
as well as interactions between intestinal epithelial cells
and microbes or immune cells [10, 11]. However, 3D
organoid culture is technically challenging, requires ex-
pensive growth factors, and has the limitation of acces-
sing only the apical side of the cells when assessing
interaction with microorganisms or other components
[11, 12]. Directed differentiation of PSC sources such as
embryonic stem (ES) cells and induced pluripotent stem
(iPS) cells can also be used to create functional intestinal
epithelium [13]. PSC are grown under conditions that
mimic normal in vivo development and undergo
step-wise differentiation that result in normal intestinal
epithelium useful for studying the molecular basis of in-
testinal disease. However, these cultures are character-
ized as fetal in nature, which limits their usefulness in
adult functional assays of mature intestinal epithelium
[13, 14]. In addition, these cultures are expensive, com-
plex and time-consuming.
Conditional reprogramming has been recently intro-
duced as a method to indefinitely propagate multiple
epithelial cell types in vitro by co-culture with irradiated
fibroblast feeder cells and the Rho kinase (ROCK) in-
hibitor Y-27632 [15]. Under these conditions, epithelial
cells are induced to an adult stem cell-like state that al-
lows expansion and maintenance of lineage commitment
[15, 16]. Success has been demonstrated with a variety
of epithelial cell types including prostate, mammary and
lung epithelium with limited success in liver and colon
epithelium [15]. This exciting advance has allowed ex-
pansion and in vitro study of previously difficult to grow
cell sources. Recent reports have demonstrated success-
ful cloning and propagation of ground state human in-
testinal stem cells (ISCGS) using similar culture
conditions including a feeder cell layer and ROCK in-
hibitor [17]. ISCGS differentiated by air liquid interface
(ALI) culture and treated with C. difficile toxins pro-
duced an inflammatory response demonstrating their
functional capacity [17]. Cultures that allow the ability
to expand intestinal epithelial cells from human biopsies
provide a valuable cell source for disease modeling and
regenerative medicine.
Long-term expansion of untransformed intestinal epi-
thelium from genetic mouse models as a monolayer would
provide a new platform for assays of intestinal physiology
and mechanistic studies that have previously been very
difficult. Genetic mouse models are available for many dis-
orders affecting the gastrointestinal tract including cystic
fibrosis (CF) and intestinal carcinoma. Cystic fibrosis (CF)
affects mucus producing epithelium including lung and
intestine and is caused by mutations in the cystic fibrosis
transmembrane conductance regulator (CFTR) gene. The
most common cause of CF is a deletion of phenylalanine
at position 508 (CFTR ΔF508) that causes protein mis-
folding and early degradation which prevent CFTR from
reaching the plasma membrane and make it nonfunctional
[18]. Recent studies have demonstrated the effective use
of intestinal organoids derived from primary intestinal bi-
opsy in functional CFTR assays [19]. Mutation in the ad-
enomatous polyposis coli (APC) gene results in the
formation of spontaneous intestinal cancers. The ApcMin/+
mouse model [20, 21], which carries loss of Apc function,
causes constant Wnt stimulation that leads to increased
expression of β-catenin dependent genes that are associ-
ated with cell cycle, resulting in excess intestinal epithelial
cell proliferation and adenoma formation in the small in-
testine and colon [22].
Primary cultures of intestinal epithelium from genetic
mouse models achieved by conditional reprogramming
provide a physiologically relevant approach to study the
mechanisms and novel therapeutics for diseases includ-
ing CF and intestinal tumorigenesis. Our goal was to
achieve long-term culture of untransformed IEC and
permit functional studies in vitro. Using a slight modifi-
cation of the previously reported conditional reprogram-
ming protocol [15], we derived 2D mouse intestinal
epithelial monolayers (IEC monolayers) from frozen bi-
opsies of wild-type (WT), CFTR ΔF508 and ApcMin/+
mouse small intestines. IEC monolayers demonstrated
rapid monolayer growth, epithelial phenotype and main-
tenance of genotype with passage. IEC monolayers de-
rived from these genetic mouse models retain
functionality as demonstrated by decreased response of
CFTR ΔF508 IEC monolayers to CFTR activation and
increased growth rate of ApcMin/+ IEC monolayers. We
conclude that culture under slightly modified conditional
reprogramming conditions allows long-term propagation
of untransformed, functional monolayers of mouse intes-
tinal epithelial cells from genetic models that may be
used in functional studies to examine the physiology of
intestinal disorders and to identify effective treatments.
Methods
Mice
CFTR ΔF508 mice on C57BL/6 N background were ob-
tained from UNC Cystic Fibrosis Center Mouse Core. Apc-
Min/+ mice on C57BL/6 background were originally
purchased from The Jackson Laboratory (Bar Harbor, ME),
and breeding was continued at the University of North Car-
olina (Chapel Hill). All animals were maintained in accord-
ance with the Institutional Animal Care and Use
Committee (IACUC) (protocol #: 16–193) of the University
of North Carolina.
Mouse tissue harvesting and cryopreservation
After the intestine tissue was dissected, the whole intes-
tine was flushed with ice cold Phosphate buffered saline
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(PBS) three times. Intestine tissues were cut open longi-
tudinally. Full thickness proximal duodenum (0.5 cm)
was isolated from WT or CFTR ΔF508 mice between
6 weeks to 5 months of age and small intestinal tumors
were isolated from ApcMin/+ animals at 4 months of age.
Both male and female mice were used. Full thickness
small intestine or tumor was minced into pieces less
than 3 mm in size using a razor blade. The minced tis-
sue was re-suspended in Freezing Medium (90% fetal
bovine serum (FBS) (Gemini, Sacrament, CA)/ 10%
DMSO (v/v; Sigma-Aldrich, St. Louis, MO)/ 10 μM
Y-27632 (Enzo Life Sciences, Farmingdale, NY), frozen
in an isopropanol chamber at − 80 °C overnight and
transferred to liquid nitrogen for long term storage.
Tissue processing
Minced, frozen tissue was processed as previously de-
scribed [15]. Briefly, tissue was thawed at 37 °C and
washed by addition of Wash Medium (Dulbecco’s modi-
fied Eagle’s medium (DMEM) high glucose containing
10% FBS (Gemini, Sacrament, CA), 100 μg/mL penicil-
lin, 100 μg/mL streptomycin, 100 μg/mL Glutamax,
2.5 μg/ml Amphotericin B (Life Technologies, Carlsbad,
CA) and 10 μM Y-27632 (Enzo Life Sciences, Farming-
dale, NY) and collected by gravity sedimentation.
Minced tissue was then re-suspended in F medium (3:1
(v/v) F-12 Nutrient Mixture (Ham) – DMEM high glu-
cose, 5% FBS, 0.4 μg/mL hydrocortisome (Sigma-Al-
drich, St. Louis, MO), 5 μg/mL insulin (Sigma-Aldrich,
St. Louis, MO), 8.4 ng/mL cholera toxin (Sigma-Aldrich,
St. Louis, MO), 10 ng/mL EGF (Life Technologies,
Carlsbad, CA), 10 μM Y-27632 (Enzo Life Sciences,
Farmingdale, NY)) containing 2.4 mg/mL Collagenase
Type I (Sigma-Aldrich, St. Louis, MO) and 0.3 Units/mL
Dispase (Corning, Corning, NY) and was incubated at
room temperature for 25 min with rocking. Tissue was
broken down by vigorous pipetting and filtered through
a 70 μm cell strainer (Fisher Scientific, Waltham, CA).
Cells were washed with Wash Medium and collected by
centrifugation at 1500 rpm for 5 min. Cells were
re-suspended in F medium containing 50 ng/ml EGF
(R&D Systems, Minneapolis, MN), 100 ng/ml Noggin
(Peprotech, Rocky Hill, NJ) and 1 μg/ml R-spondin
(R&D Systems, Minneapolis, MN) and plated onto pre-
viously prepared Purcol (Advanced Biomatrix, Carlsbad,
CA) coated dishes with single layer of irradiated 3T3-J2
feeder cells.
IEC monolayer maintenance
Approximately 24 h after the initial seeding, F medium
containing growth factors (EGF, Noggin, R-spondin) was
removed and medium was changed to F medium alone
with no added growth factors. IEC monolayers were
then maintained long-term in F medium alone with
medium changes every other day [5]. IEC monolayers
were passaged at confluence approximately every 3–
4 days using double trypsinization at a ratio of approxi-
mately 1:6 onto a fresh irradiated 3T3-J2 feeder layer in
F medium alone.
Feeder cell preparation
Swiss 3T3 mouse fibroblast (J2 strain) feeder cells [23, 24]
were prepared as previously described [15]. Briefly, live
3T3-J2 cells were maintained in a 37 °C incubator with 5%
CO2 in Complete Medium (DMEM high glucose contain-
ing 10% FBS (Gemini, Sacrament, CA), 100 μg/mL penicil-
lin, 100 μg/mL streptomycin, and 100 μg/mL Glutamax
(Life Technologies, Carlsbad, CA)). Feeder cells were re-
moved from flasks at 80–90% confluence using 0.05%
trypsin-EDTA (Life Technologies, Carlsbad, CA),
re-suspended in Complete Medium at a concentration of
5 × 106 cells per ml and irradiated at 30 Gy in an RS-2000
(Rad Source, Suwanee, GA) machine. Irradiated 3T3-J2
cells were plated onto Purcol (Advanced Biomatrix, Carls-
bad, CA) coated dishes to achieve 80% confluence and were
allowed to attach for at least 4 h before the addition of in-
testinal epithelial cells.
Immunofluorescence staining
IEC monolayers were plated under maintenance condi-
tions mentioned above onto glass slides. After 2 days,
IEC monolayers on slides were washed 2 times in 1XPBS
for 5 min each, fixed in 4% paraformaldehyde for 15 min
at room temperature and washed again with 1XPBS for
5 min each. Cells were blocked using 5% normal goat
serum for 1 h at room temperature. E-cadherin (1:100;
Cat# 3195; Cell Signaling Technology, Danvers, MA)
and ZO-1 (1:25; Clone# R40.76; a kind gift from Dr.
Alan Fanning; UNC-Capel Hill) antibodies were diluted
in permeabilization buffer (5% normal goat serum/0.5%
Triton-X in PBS) and incubated on cells overnight at 4 °
C. Following antibody incubation, cells were washed 3
times in 1XPBS for 5 min each. Secondary antibodies
were diluted in permeabilization buffer (1:300; Cat#111–
165-003, Cat# 112–165-003; Jackson Labs, Bar Harbor,
ME) and incubated with cells for 2 h at room
temperature in the dark. Cells were washed 2 times with
1XPBS for 5 min each. Slides were mounted using DAPI
mounting medium (Vector Labs, Burlingame, CA) and
imaged using a fluorescent microscope (Olympus IX81;
Olympus, Center Valley, PA).
Flow cytometry
IEC monolayers were separated from 3T3-J2 feeder cells
by double trypsinization, washed once with PBS and
re-suspended in Staining Buffer (PBS, 1% FBS (Gemini,
Sacrament, CA)) at a concentration of approximately 1 ×
106 per ml. Cells were incubated with a PE conjugated
Moorefield et al. BMC Cell Biology  (2018) 19:15 Page 3 of 11
EpCAM antibody (1:100; clone G8.8; Biolegend, San
Diego, CA) for approximately 30 min on ice. Cells were
washed twice in Staining Buffer and analyzed using a Cyan
flow cytometer and Summit v4.3 software (Beckman
Coulter, Brea, CA). EpCAM expression was assessed in
IEC monolayers from 3 individual mice. 3T3-J2 feeder
cells were used as negative controls.
Polymerase chain reaction (PCR)
Genomic DNA was extracted from IEC monolayers and
3T3-J2 feeder cells using the DNeasy kit (Qiagen, Valencia,
CA) according to the manufacturer’s protocol. Genotyping
was performed by combining Apex Taq DNA Polymerase
2× Master Mix (Genesee Scientific, Morrisville, NC) with
0.5 nM of each primer and genomic DNA. ApcMin/+ primer
sequences are: APC F: 5′-TTCTGAGAAAGACAGAAGT
TA-3′ and APC R: 5′-TTCCACTTTGGCATAAGGC-3′.
The PCR conditions were 95 °C for 15′ followed by 40 cy-
cles of 95 °C for 30″, 59 °C for 30″ and 72 °C for 1′ and an
extension of 72 °C for 5′. CFTR ΔF508 genotyping was per-
formed according to the Jackson Labs (Bar Harbor, ME)
protocol. CFTR ΔF508 primer sequences are: IMR0269:
5′-TTCAAGCCCAAGCTTTCGCGAG-3′, IMR0270:
5′-CTCCCTTCTTCTAGTCACAACCG-3′ and IMR0271:
5′-CATCTTGATAGAGCCACGGTGC-3′. The PCR con-
ditions were 94 °C for 3′ followed by 12 cycles of 92 °C for
20″, 64 °C for 30″ and 72 °C for 35″ decreasing the
annealing temperature by 0.5 °C each cycle. Then 25 cycles
of 94 °C for 20″, 58 °C for 30″ and 72 °C for 35″ were
completed followed by an extension of 72 °C for 2′.
Three-dimensional (3D) matrigel culture of IEC
monolayers
After double trypsinization, IEC monolayers were
counted and approximately 5000 IEC monolayers, which
might include small amount of feeder cells, were seeded
in 10 μl Low Growth Factor Matrigel (Corning, Corning,
NY) and then were loaded in the center of the well of
pre-warmed 48 well plate. After polymerization by incu-
bating at 37 °C for 20 min, 350 μl Advanced
DMEM-F12 containing N2 supplement without vitamin
A, B27 supplement, 10 mM HEPES, 100 μg/mL penicil-
lin, 100 μg/mL streptomycin, 100 μg/mL Glutamax (Life
Technologies, Carlsbad, CA), 50 ng/ml EGF (R&D Sys-
tems, Minneapolis, MN), 100 ng/ml Noggin (Peprotech,
Rocky Hill, NJ) and 1 μg/ml R-spondin (R&D Systems,
Minneapolis, MN) was added to each well. Medium was
changed every other day with growth factors at the same
concentrations as the initial plating except R-spondin,
which was reduced to 500 ng/mL.
Spheroid stimulation assay and swelling quantification
WT and CFTR ΔF508 spheroids were grown in matrigel
culture for 4–5 days after seeding, and then treated with
forskolin to activate CFTR. A subset of WT spheroids
were pretreated for 3 h with 50 μM CFTRinh-172 to
block CFTR function prior to forskolin treatment. WT
and CFTR ΔF508 spheroids received a medium change
with or without the addition of 5 μM forskolin. Spher-
oids were imaged at time 0 and 60 min after the medium
change using an inverted fluorescent microscope (IX83;
Olympus, Center Valley, PA). Spheroid swelling was
quantified by measuring spheroid diameter using Image
J software (NIH, Bethesda, MD). The percent increase in
spheroid surface area at time 60 min relative to time 0
was calculated. Forskolin response was tested in WT
IEC monolayers from 3 individual mice and CFTR
ΔF508 IEC monolayers from 3 individual mice.
Transwell culture conditions
WT and CFTR ΔF508 IEC monolayers were plated in F
medium on 12-well Snapwell inserts (Costar, Fisher,
Pittsburg, PA) at a concentration of approximately
300,000 cells per insert. Twenty four hours after plating,
the medium was changed to Advanced DMEMF-12 con-
taining 20% FBS (Gemini, Sacrament, CA), 100 μg/mL
penicillin, 100 μg/mL streptomycin, and 100 μg/mL Glu-
tamax (Life Technologies, Carlsbad, CA) and 10 μM
DAPT (Stem Cell Technologies, Vancouver, Canada) to
induce differentiation. Transwells were maintained by
changing medium every other day and electrophysio-
logical analysis was performed 6–8 days after seeding
until cells become confluent.
Electrophysiological measurements
Transepithelial Cl− secretion in IEC monolayers mono-
layer cultures were measured in modified Ussing cham-
bers using Acquire & Analyze Software (Physiologic
Instruments, San Diego, CA). Chamber temperature was
maintained at 36 °C ± 1o C by a circulating water bath,
and agar bridges were equilibrated in 5 mL bilateral
Krebs bicarbonate ringers solution (KBR; 120 mM Cl−,
25 mM HCO3−, 140 mM Na+, 5.2 mM K+, 1.2 mM Ca2+,
1.2 mM Mg2+, 2.4 mM HPO4
2-, 0.4 mM H2PO4
−) with
5 mM mannitol (mucosal), 5 mM D-glucose (serosal), and
circulated with 95% O2 and 5% CO2 gas, at pH = 7.4. Prior
to data acquisition, IEC monolayers cultures were
mounted and reference measurements for potential differ-
ence (PD) and transepithelial resistance (Rt) were re-
corded. IEC monolayers cultures were voltage clamped,
and measurements were recorded digitally every 20 s. Cul-
tures were equilibrated for a minimum of 10 min prior to
the addition of agonists or inhibitors. Compounds (ob-
tained from Sigma, except UTP from GE Healthcare) were
added in order as indicated: amiloride, 100 μM (mucosal)
to inhibit ENaC; forskolin, 10 μM/ IBMX, 100 μM
(mucosal and serosal) to induce cAMP activation of
CFTR, UTP 100 μM (mucosal) to activate Ca2+-activated
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Cl− channels (CaCC), and GlyH-101 (50 μM, muco-
sal) to inhibit Cl− channel current. Data was imported
and processed in Microsoft Excel and Origin 9.0.0.
(OriginLab Corporation). Electrophysiological mea-
surements were performed on IEC monolayers
derived from 2 individual WT mice and 3 individual
CFTR ΔF508 mice.
Quantification of IEC monolayers colony expansion
WT and ApcMin/+ Tumor IEC monolayers were plated
onto feeder-coated dishes in F medium. Cells were
maintained by changing F medium every other day. On
day 2 after plating, IEC monolayers colonies were identi-
fied and imaged using an inverted fluorescent micro-
scope with an incubation chamber (IX83; Olympus,
Center Valley, PA). The same IEC monolayers colonies
were tracked and imaged at days 3 after plating. IEC
monolayers colony size was quantified at each time
point by measuring colony diameter using ImageJ soft-
ware (NIH, Bethesda, MD). Colony expansion was
assessed in 3 individual WT IEC monolayers and 3 indi-
vidual ApcMin/+ tumor IEC monolayers.
Quantification of IEC monolayers spheroid growth
WT and ApcMin/+ tumor IEC monolayers were passaged
into matrigel (Matrigel Matrix, Corning, Cat# 354230,
New York) to grow as spheroids, where they were
tracked and measured to assess growth rate. At day 3, 5
and 7 after plating, images from the spheroids were
taken from WT and ApcMin/+ tumor IEC monolayers
spheroids using an inverted fluorescent microscope
(IX85; Olympus, Center Valley, PA). Spheroid size was
quantified at each time point by measuring spheroid
diameter using ImageJ software (NIH, Bethesda, MD).
Spheroid growth was assessed in IEC monolayers de-
rived from 3 individual WT and 3 individual ApcMin/+
tumor samples.
Statistical analysis
Data represent means ± SEM. Data was analyzed using
Student’s t-test in Graphpad Prism 5.0. P < 0.05 was con-
sidered statistically significant.
Results
Long-term expansion of normal adult mouse small
intestinal epithelium culture under modified conditional
reprogramming conditions
Based on previous successful reports of conditionally repro-
gramming variety of epithelial cell types [15] and selective
expansion of human ground state intestinal stem cells
(ISCGS) [17], we aimed to expand mouse intestinal epithe-
lium using similar conditions. We applied modified condi-
tional reprogramming culture conditions to mouse small
intestine or small intestinal tumor to achieve long-term
growth of intestinal epithelial monolayers. Culture of cryo-
preserved mouse intestine with ROCK inhibitor and irradi-
ated 3T3-J2 feeder cells with initial addition of growth
factors critical in intestinal development and intestinal stem
cell maintenance resulted in mouse intestinal epithelial
monolayers (IEC monolayers) having consistent cuboidal
morphology and growing in tight, rapidly expanding col-
onies in early, and later passages (Fig. 1a, b, d). To date,
IEC monolayers have shown the ability to grow under
modified conditional reprogramming conditions for up to
3 months with no change in morphology or passaging rate.
The epithelial nature of IEC monolayers was confirmed by
using flow cytometry to test for the presence of the epithe-
lial specific surface marker EpCAM. Around 95% of col-
lected IEC monolayers expressed EpCAM demonstrating
that we are able to specifically expand epithelial cells from
the mouse small intestine (Fig. 1c). The remainder of the
cells not expressing EpCAM (approximately 5% of the
culture) may be residual feeder cells which are mes-
enchymal in origin. Formation of tight junctions was
confirmed by immunofluorescent staining for
E-cadherin and ZO-1 (Fig. 1e).
Maintenance of mutant allele
Maintaining presence of a parental mutant allele across
passage is critical for the usefulness of IEC monolayers
in functional assays. Genomic DNA was isolated from
IEC monolayers following several passages to determine
the ability of IEC monolayers to retain the mutation
present in the parental intestinal epithelium across pas-
sage. Figure 2a indicates that WT IEC monolayers main-
tained the presence of the normal CFTR gene and IEC
monolayers derived from CFTR ΔF508 animals main-
tained the CFTR ΔF508 mutation over prolonged passa-
ging (passage 11–13). In the model of intestinal cancer,
we observed maintenance of the mutated APC gene in
IEC monolayers derived from intestinal tumors of
ApcMin/+ animals (Fig. 2b).
Functional studies of CFTR ΔF508 mouse IEC monolayers
IEC monolayers derived from WT and CFTR ΔF508 ani-
mals were used to assess CFTR functionality in long-term
intestinal epithelial cell culture. IEC monolayers were ex-
panded as monolayers on feeder cells with ROCK inhibi-
tor and then was plated into matrigel and Transwell
culture systems to assess their response to CFTR activa-
tion. To demonstrate CFTR function, we performed the
previously described forskolin-induced swelling assay on
WT and CFTR ΔF508 IEC monolayers spheroids grown
in matrigel [19]. Forskolin functions by raising the levels
of intracellular cAMP which activates CFTR gene and
causes fluid secretion into the lumen resulting in swelling
of 3D intestinal structures [19]. We observed that IEC
monolayers collected from feeder cultures were
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successfully grown in matrigel, and formed 3D spheroids
making them ideal for use in this assay (Fig. 3a). WT IEC
monolayer derived spheroids treated with forskolin
swelled significantly over the 60 min time period com-
pared to their size prior to treatment revealing functional
CFTR (Fig. 3a, b). To demonstrate that forskolin-induced
swelling was dependent on CFTR, we pre-treated WT
IEC monolayer derived spheroids with the CFTR inhibitor
CFTRinh-172 then added forskolin and assessed swelling
response. WT IEC monolayer derived spheroids with
CFTR inhibitor treatment do not swell significantly in the
presence of forskolin indicating that this response is CFTR
dependent (Fig. 3a, b). CFTR ΔF508 IEC monolayer de-
rived spheroids treated with forskolin revealed no signifi-
cant increase in organoid diameter at 60 min after the
addition of forskolin compared to time 0 (Fig. 3a, b), dem-
onstrating the maintenance of dysfunctional CFTR in IEC
monolayers derived from CFTR ΔF508 mice. Culture of
intestinal epithelial cell lines on microporous membranes
such as Transwell inserts has been shown to lead to cell
differentiation and polarization [25]. Recent studies have
demonstrated the ability of intestinal organoids cultured
on Transwells in the presence of γ-secretase inhibitor
DAPT to form functional monolayers capable of transport
[10]. We densely plated IEC monolayer cells on Transwell
inserts with DAPT treatment to achieve a functional intes-
tinal epithelial monolayer. Both WT and CFTR ΔF508
IEC monolayers formed confluent, planar cultures under
these conditions allowing electrophysiological assays to
test cellular responses to CFTR activating drugs in Ussing
chambers. We detected noticeable responses in
CFTR-mediated short-circuit current (Isc) to cAMP in-
crease by forskolin and the cAMP phosphodiesterase in-
hibitor 3-isobutyl-1-methylxanthine (IBMX) in WT but
not CF IEC monolayer derived transwell cultures (Fig. 4b,
**p < 0.001). We found no statistical difference between
IEC monolayer derived transwell cultures from CF vs. WT
mice in the amplitude of responses of transient calcium
activated Cl- channels (CaCCs) to UTP. Inhibition with
GlyH-101, which is known to inhibit CFTR and CaCC ac-
tivity [26], showed a significant difference in ΔIsc of WT
and CF cultures (Fig. 4b *p < 0.05). Figure 4a shows a sam-
ple trace from a WT IEC monolayer derived transwell cul-
ture (black) and a CFTR ΔF508 IEC monolayers
monolayer (red). These observations indicate dysfunc-
tional CFTR from CFTR ΔF508 IEC monolayers (Fig. 4c).
A
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Fig. 1 Mouse small intestinal epithelial cells divide and maintain morphology with passage and express epithelial cell markers when
cultured under modified conditional reprogramming conditions. a Representative phase contrast images of IEC monolayer colonies 1 day
post-plating and 4 days after post-plating (passage 12). Dashed circle indicates colonies. Images were taken at 10× magnification. Scale
bar: 100 μm. b Representative image of colony with higher magnification (20×) c Representative flow cytometry plot of EpCAM
expression in IEC monolayers. Data represents IEC monolayers from 3 individual mice and diverse passages. d Representative phase
contrast images of IEC monolayers colonies at early, middle and later passages. e Representative fluorescence microscopy images of IEC
monolayers stained with tight junction markers E-cadherin and ZO-1
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Functional studies of ApcMin/+ mouse tumor IEC monolayers
WT and ApcMin/+ tumor IEC monolayer growth was
evaluated both as a monolayer on 3T3-J2 feeder cells
and in the 3-D matrigel system, and then their function-
ality was assessed. Prior to the first passage (on passage
0 after freshly isolated cell plating), we evaluated the ex-
pansion rate of IEC monolayers by measuring the diam-
eter of the growing IEC monolayer colonies over time.
ApcMin/+ tumor IEC monolayers grown as a monolayer
under conditional reprogramming conditions demon-
strated a faster growth rate as measured by the
significantly higher increase in colony diameter between
days 2 and 3 compared to WT IEC monolayers (Fig. 5a,
b). We also passaged both WT and ApcMin/+ tumor IEC
monolayers into matrigel conditions and assessed the
growth rate of WT and ApcMin/+ IEC monolayer derived
spheroids grown in matrigel by measuring spheroid
diameter. ApcMin/+ IEC monolayer derived spheroids
grew faster than WT IEC monolayer derived spheroids
with significantly higher fold change in spheroid diam-
eter at day 5 and day 7 compared to WT IEC monolayer
derived spheroids (Fig. 5c, d).
A B
Fig. 2 Small intestinal IEC monolayers from WT, CFTR ΔF508 and ApcMin/+ mice maintain presence of mutant allele across passages. a Genomic
DNA isolated from IEC monolayers derived from wild-type (WT) or cystic fibrosis (CFTR ΔF508) mouse models amplified by CFTR primers. WT IEC
monolayers and irradiated 3T3-J2 feeders contain the normal length CFTR gene and CFTR ΔF508 IEC monolayers contains the truncated CFTR
gene. b Genomic DNA isolated from IEC monolayers derived from WT or intestinal cancer (ApcMin/+) mouse models. IEC monolayers from ApcMin/+
mouse model contains the mutant Apc gene. n = 3 individual animals in each genetic mouse model
A B
Fig. 3 Mouse CFTR ΔF508 IEC monolayers retains CFTR dysfunction in intestinal epithelium. a Representative images of WT and CFTR ΔF508 IEC
monolayer derived spheroids grown in matrigel and treated with forskolin (Fsk) to induce spheroid swelling. Images were taken at 10×
magnification. Scale bar: 100 μm. White dashed line: representation of spheroid diameter measurement. b Quantification of WT and CFTR ΔF508
IEC monolayers swelling in response to CFTR activation (Forskolin, Fsk) and inhibition (CFTRinh-172). *p < 0.05, n = 3 individual animals in each
treatment group
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Discussion
Here we demonstrate a system to rapidly expand func-
tional intestinal epithelial cells; a process that allows
long-term propagation of intestinal epithelial cells in a
monolayer format. Conditional reprogramming employs
the use of irradiated feeder cells and a Rho kinase (ROCK)
inhibitor to induce normal and tumor epithelial cells to
long-term proliferation in vitro without the need for ex-
ogenous gene transduction [15]. When cultured with
ROCK inhibitor Y-27632 in the presence of a fibroblast
feeder layer, mouse intestinal epithelial monolayers (IEC
monolayers) grow in a monolayer format that is capable
of rapid expansion, maintains specific mutant allele and is
suitable for functional analyses. IEC monolayers circum-
vent many of the issues present in current methods of in
vitro intestinal epithelial cell culture and provide a way to
generate large numbers of untransformed primary intes-
tinal epithelium from a variety of genetic mouse models.
Expansion of IEC monolayers on feeder cells is critical
to achieve large cell numbers, but their ability to survive
and grow after transfer to additional culture systems is
critical for functional analysis of disease in vitro. Primary
prostate and mammary cells are rapidly reprogrammed to-
ward an adult stem cell-like phenotype that are able to
form prostaspheroids and mammospheroids in matrigel
[15]. IEC monolayers are able to form 3D spheroids when
transferred to Matrigel culture that are similar in appear-
ance to intestinal epithelial stem cell or crypt derived
enterospheres. IEC monolayer derived spheroids have
proven valuable in testing CFTR modulator compounds
and cell proliferation rates and may also be useful for
examining host-pathogen interactions in vitro. When
transferred to a semi-permeable insert in a Transwell for-
mat, IEC monolayer cells form a confluent monolayer.
Culture in the Transwell system allows IEC monolayers to
be tested in electrophysiology assays and may be used to
study intestinal permeability and transport. Importantly,
both the Matrigel and Transwell systems achieve IEC
monolayer culture in the absence of a feeder layer which
allows for cleaner studies of cell signaling and facilitates
more advanced functional studies.
We established IEC monolayers from mice homozygous
for the most common CFTR mutation, deletion of phenyl-
alanine at position 508 (ΔF508), which causes loss of
CFTR function through misfolding, endoplasmic
reticulum (ER) retention and early degradation [27]. Mice
carrying the ΔF508 mutation display a relatively severe in-
testinal pathology consistent with the CF related intestinal
dysfunction observed in humans [28]. The ΔF508 mutant
mouse model has been used to study CFTR processing
A
B C
Fig. 4 Electrophysiological measurements of WT and CF mouse IEC monolayers. a Representative traces of electrophysiological measurements of
WT and CF mouse IEC monolayers in Ussing chambers. Amiloride (Amil), Forskolin + IBMX (Fsk/IBMX), UTP and GlyH-101 were added sequentially.
b Mean Forskolin/IBMX, UTP and GlyH101 responses measured in Ussing chambers. Electrophysiological measurements were performed on IEC
monolayers derived from 2 individual WT mice and 3 individual ΔF508 CFTR mice. c Measured bioelectric characteristics of WT and CF IEC
monolayer mouse small intestinal cultures. Basal potential difference (mV), transepithelial resistance (Ω x cm2), and current (μA/cm2) are
reported. Data represented at mean ± SEM based on cultures. *p < 0.05
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and transportation defects and to test possible therapeutic
compounds [29]. In the current study, we have success-
fully grown 3D spheroids from WT IEC monolayers and
ΔF508 IEC monolayers plated in matrigel conditions. The
ability to form sphereoids is a critical element of assessing
CFTR functionality. The recently developed forskolin
swelling assay creates a platform to directly examine
CFTR function in early organoid cultures [19, 30].
Transwell culture is critical for electrophysiological ana-
lysis of CFTR function. This is the first time, to our know-
ledge, that electrophysiology has been successfully
preformed on primary monolayer cultures of intestinal
epithelial cells. We detected two mechanisms of Cl− secre-
tion: 1) cAMP-mediated by CFTR and 2) purinergic acti-
vation of CaCCs. We found a substantial difference in the
amplitude of response to forskolin and IBMX, showing
that CFTR is present in the small intestine of WT mice
and is responsible for a portion of Cl− and/or bicarbonate
transport in this region. In both ΔF508 CFTR and WT
mice, we found no statistical difference in the amplitude
of the Ca2+ activated Cl− channel response to the P2Y re-
ceptor agonist, UTP. The difference in inhibition of
short-circuit current by GlyH-101 in WT and CF cultures
reveals further evidence that Cl− channels are active in
IEC monolayer cultures, but abrogated in CF IEC mono-
layer cultures.
In previous studies, conditionally reprogrammed cells
(CRC) have been created from carcinomas including
breast tumors of transgenic mice and DMBA-treated rats
allowing for molecular analysis [15]. In clinic, CRC have
also been created from tumor epithelium of a recurrent
respiratory papillomatosis (RPP) and used to successfully
identify an effective treatment [31]. We derived IEC
monolayers from the intestinal tumor tissue of ApcMin/+
mouse intestinal cancer model. ApcMin/+ mouse model
carries a heterozygous germ line mutation at codon 850 of
the tumor suppressor adenomatous polyposis coli (APC)
gene [32] and loss of the normal Apc allele in intestinal
epithelium leads to intestinal adenoma formation [33].
The ApcMin/+ mouse model is commonly used to investi-
gate the molecular mechanisms behind initiation and pro-
gression of intestinal tumorigenesis and to study
preventative and therapeutic approaches to intestinal can-
cer in vivo as mice develop many adenomas in the small
intestine and colon in the first 6 months of life [34]. In the
present study, we demonstrate that ApcMin/+ tumor IEC
monolayers retain cancerous phenotype and expand much
more quickly under normal growth conditions and in 3D
matrigel conditions than WT IEC monolayers. To date, in
vitro studies rely on transformed cell lines that are genet-
ically unstable and do not effectively represent tumor
physiology [35]. ApcMin/+ IEC monolayers could be used
A B
C D
Fig. 5 Mouse ApcMin/+ tumor IEC monolayers retain functional characteristics of intestinal epithelium. a Representative images of WT and ApcMin/+
tumor IEC monolayers colonies growing on a feeder layer at passage 0. b Quantification of WT and ApcMin/+ tumor IEC monolayer colony growth
between days 2 and 3 post-plating. c Representative images of WT and ApcMin/+ tumor IEC monolayer derived spheroids grown in matrigel. d
Quantification of WT and ApcMin/+ tumor IEC monolayer derived spheroid growth based on spheroid diameter on day 5 and day 7 compared to
day 3. *p < 0.05, n = 3 individual animals in each genetic mouse model
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as an in vitro model to identify the molecular basis of
tumor progression and to study factors that may promote
or prevent tumor progression. Specifically, ApcMin/+ IEC
monolayers may be used to investigate signaling pathways
involved in tumorigenesis by overexpression or knock-
down of key genes. Established IEC monolayers are an in-
valuable tool to study the role of therapeutic substances
able to prevent molecular and phenotypic progression of
carcinoma.
The goal of our study is to expand normal intestinal epi-
thelium as IEC monolayers and to use these cells in func-
tional assays. However, additional experiments are
required to fully characterize IEC monolayers. CRC have
been shown to share properties with adult stem cells and
keratinocyte CRC express markers consistent with epithe-
lial stem cells [16]. Studies directly comparing the gene
and protein expression profiles of IEC monolayers with
IESC and intestinal progenitor cells would be useful to de-
termine their characteristics. CRC have also been shown
to maintain tissue-specific differentiation potential. Under
air-liquid interface (ALI) culture conditions, cervical CRC
are able to form a stratified epithelium that expresses pro-
teins of the mature cervix while tracheal CRC differentiate
to form a mucociliary airway epithelium [16]. Additional
experiments on IEC monolayer derived spheroids and
Transwell culture are necessary to determine the full ex-
tent of their differentiation.
Taken together, our results support the use of IEC
monolayers from genetic mouse models as an in vitro
system to study molecular mechanisms causing intes-
tinal disease and to identify effective therapeutics. We
have demonstrated the ability of IEC monolayers to
be useful in examining CFTR and Apc dysfunction.
This system may be expanded to allow the growth of
intestinal epithelium from mice with many different
genetic mutations to allow physiologically relevant
disease modeling. The ability to rapidly expand intes-
tinal epithelium from mutant mouse models will pro-
vide a large number of functional cells for a variety
of downstream analyses including barrier function,
host-microbe interaction and epithelial-stromal inter-
action. High cell yields from a single biopsy also pro-
vide the possibility for longitudinal studies and high
throughput screening assays.
Conclusion
Mutant mouse IEC monolayers constitute an in vitro
model to promote understanding of the molecular basis
of genetic disease and contribute to the identification of
novel therapeutic approaches.
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